Prestigious NHMRC Investigator Grants awarded to seven QIMR Berghofer scientists

17 October 2022

QIMR Berghofer has been awarded seven National Health and Medical Research Council (NHMRC) grants, that will help drive vital research in the areas of malaria, cancer and genomics, lupus and mental health.

The Investigator Grant scheme is the NHMRC’s largest funding scheme which awards around $370 million in research funding each year to support emerging and established leaders in health and medical research.

The grants are highly contested, providing a 5-year fellowship and research support for outstanding researchers at all career stages.

Congratulations to the following QIMR Berghofer researchers and their teams.

NHMRC Investigator Grants:

Leveraging genomics to unravel tumour complexity and improve patient outcomes.

Malaria volunteer infection studies for the advancement of antimalarial therapeutics.

Cancer and the dark genome.

Breakthrough research paving the way for the development of transformative immunotherapies for Systemic lupus erythematosus (SLE).

Understanding the genetic basis of treatment response for depression.

Expanding genetic causal inference analyses to evaluate cancer risk factors in diverse populations.

Prolonging survival in glioblastoma through targeting of quiescent glioma stem cells.

More information about the grants is available from the NHMRC.


Bridie Barry
T +617 3362 0233
M +614 2859 2194